scispace - formally typeset
Search or ask a question
Author

Thomas J. Mariani

Bio: Thomas J. Mariani is an academic researcher from University of Rochester. The author has contributed to research in topics: Lung & Gene expression profiling. The author has an hindex of 39, co-authored 149 publications receiving 6902 citations. Previous affiliations of Thomas J. Mariani include Brigham and Women's Hospital & University of Rochester Medical Center.


Papers
More filters
Journal ArticleDOI
TL;DR: Three unique and highly compartmentalized mammalian superoxide dismutases have been biochemically and molecularly characterized to date and a molecular understanding of each of these genes has proven useful toward the deciphering of their biological roles.

1,870 citations

Journal ArticleDOI
30 Mar 2006-Oncogene
TL;DR: Surprisingly, K-ras activation in the bronchiolar epithelium is associated with a robust inflammatory response characterized by an abundant infiltration of alveolar macrophages and neutrophils and provides an excellent means to further study the complex interactions between inflammatory cells, chemokines and tumor progression.
Abstract: Activating mutations in K-ras are one of the most common genetic alterations in human lung cancer. To dissect the role of K-ras activation in bronchial epithelial cells during lung tumorigenesis, we created a model of lung adenocarcinoma by generating a conditional mutant mouse with both Clara cell secretory protein (CC10)-Cre recombinase and the Lox-Stop-Lox K-rasG12D alleles. The activation of K-ras mutant allele in CC10 positive cells resulted in a progressive phenotype characterized by cellular atypia, adenoma and ultimately adenocarcinoma. Surprisingly, K-ras activation in the bronchiolar epithelium is associated with a robust inflammatory response characterized by an abundant infiltration of alveolar macrophages and neutrophils. These mice displayed early mortality in the setting of this pulmonary inflammatory response with a median survival of 8 weeks. Bronchoalveolar lavage fluid from these mutant mice contained the MIP-2, KC, MCP-1 and LIX chemokines that increased significantly with age. Cell lines derived from these tumors directly produced MIP-2, LIX and KC. This model demonstrates that K-ras activation in the lung induces the elaboration of inflammatory chemokines and provides an excellent means to further study the complex interactions between inflammatory cells, chemokines and tumor progression.

238 citations

Journal ArticleDOI
TL;DR: Mechanisms underlying pathological airway responses in severe asthma include lipoxin underproduction with decreased expression of lipoxin biosynthetic enzymes and receptors.
Abstract: Rationale: Airway inflammation is common in severe asthma despite antiinflammatory therapy with corticosteroids. Lipoxin A4 (LXA4) is an arachidonic acid–derived mediator that serves as an agonist for resolution of inflammation.Objectives: Airway levels of LXA4, as well as the expression of lipoxin biosynthetic genes and receptors, in severe asthma.Methods: Samples of bronchoalveolar lavage fluid were obtained from subjects with asthma and levels of LXA4 and related eicosanoids were measured. Expression of lipoxin biosynthetic genes was determined in whole blood, bronchoalveolar lavage cells, and endobronchial biopsies by quantitative polymerase chain reaction, and leukocyte LXA4 receptors were monitored by flow cytometry.Measurements and Main Results: Individuals with severe asthma had significantly less LXA4 in bronchoalveolar lavage fluids (11.2 ± 2.1 pg/ml) than did subjects with nonsevere asthma (150.1 ± 38.5 pg/ml; P < 0.05). In contrast, levels of cysteinyl leukotrienes were increased in both asthm...

235 citations

Journal ArticleDOI
TL;DR: Genotyped and analyzed qualitative and quantitative COPD phenotypes in 635 pedigrees with 1,910 individuals and an independent case-control population that included 973 COPD cases and 956 control subjects provided further support for SERPINE2 as a COPD susceptibility gene.
Abstract: Chronic obstructive pulmonary disease (COPD) is a complex human disease likely influenced by multiple genes, cigarette smoking, and gene-by-smoking interactions, but only severe alpha 1-antitrypsin deficiency is a proven genetic risk factor for COPD. Prior linkage analyses in the Boston Early-Onset COPD Study have demonstrated significant linkage to a key intermediate phenotype of COPD on chromosome 2q. We integrated results from murine lung development and human COPD gene–expression microarray studies with human COPD linkage results on chromosome 2q to prioritize candidate-gene selection, thus identifying SERPINE2 as a positional candidate susceptibility gene for COPD. Immunohistochemistry demonstrated expression of serpine2 protein in mouse and human adult lung tissue. In family-based association testing of 127 severe, early-onset COPD pedigrees from the Boston Early-Onset COPD Study, we observed significant association with COPD phenotypes and 18 single-nucleotide polymorphisms (SNPs) in the SERPINE2 gene. Association of five of these SNPs with COPD was replicated in a case-control analysis, with cases from the National Emphysema Treatment Trial and controls from the Normative Aging Study. Family-based and case-control haplotype analyses supported similar regions of association within the SERPINE2 gene. When significantly associated SNPs in these haplotypic regions were included as covariates in linkage models, LOD score attenuation was observed most markedly in a smokers-only linkage model (LOD 4.41, attenuated to 1.74). After the integration of murine and human microarray data to inform candidate-gene selection, we observed significant family-based association and independent replication of association in a case-control study, suggesting that SERPINE2 is a COPD-susceptibility gene and is likely influenced by gene-by-smoking interaction.

212 citations

Journal ArticleDOI
TL;DR: It is shown, that at different levels of the analysis, including gene expression ratios and difference calls, cross-platform consistency is significantly improved by sequence- based matching, and evidence that sequence-based probe matching produces more consistent results when comparing similar biological data sets obtained by different microarray platforms is presented.
Abstract: Cancer derived microarray data sets are routinely produced by various platforms that are either commercially available or manufactured by academic groups. The fundamental difference in their probe selection strategies holds the promise that identical observations produced by more than one platform prove to be more robust when validated by biology. However, cross-platform comparison requires matching corresponding probe sets. We are introducing here sequence-based matching of probes instead of gene identifier-based matching. We analyzed breast cancer cell line derived RNA aliquots using Agilent cDNA and Affymetrix oligonucleotide microarray platforms to assess the advantage of this method. We show, that at different levels of the analysis, including gene expression ratios and difference calls, cross-platform consistency is significantly improved by sequence- based matching. We also present evidence that sequence-based probe matching produces more consistent results when comparing similar biological data sets obtained by different microarray platforms. This strategy allowed a more efficient transfer of classification of breast cancer samples between data sets produced by cDNA microarray and Affymetrix gene-chip platforms.

205 citations


Cited by
More filters
28 Jul 2005
TL;DR: PfPMP1)与感染红细胞、树突状组胞以及胎盘的单个或多个受体作用,在黏附及免疫逃避中起关键的作�ly.
Abstract: 抗原变异可使得多种致病微生物易于逃避宿主免疫应答。表达在感染红细胞表面的恶性疟原虫红细胞表面蛋白1(PfPMP1)与感染红细胞、内皮细胞、树突状细胞以及胎盘的单个或多个受体作用,在黏附及免疫逃避中起关键的作用。每个单倍体基因组var基因家族编码约60种成员,通过启动转录不同的var基因变异体为抗原变异提供了分子基础。

18,940 citations

Journal ArticleDOI
TL;DR: The present review provides a brief overview on oxidative stress mediated cellular damages and role of dietary antioxidants as functional foods in the management of human diseases.
Abstract: In recent years, there has been a great deal of attention toward the field of free radical chemistry. Free radicals reactive oxygen species and reactive nitrogen species are generated by our body by various endogenous systems, exposure to different physiochemical conditions or pathological states. A balance between free radicals and antioxidants is necessary for proper physiological function. If free radicals overwhelm the body's ability to regulate them, a condition known as oxidative stress ensues. Free radicals thus adversely alter lipids, proteins, and DNA and trigger a number of human diseases. Hence application of external source of antioxidants can assist in coping this oxidative stress. Synthetic antioxidants such as butylated hydroxytoluene and butylated hydroxyanisole have recently been reported to be dangerous for human health. Thus, the search for effective, nontoxic natural compounds with antioxidative activity has been intensified in recent years. The present review provides a brief overview on oxidative stress mediated cellular damages and role of dietary antioxidants as functional foods in the management of human diseases.

3,695 citations

Journal ArticleDOI
TL;DR: In this review, the cellular oxidant and antioxidant systems are summarized and the cellular effects and mechanisms of the oxidative stress are discussed.

3,573 citations

Journal ArticleDOI
TL;DR: The nuclear factor erythroid 2-related factor 2 (Nrf2) is an emerging regulator of cellular resistance to oxidants that controls the basal and induced expression of an array of antioxidant response element-dependent genes to regulate the physiological and pathophysiological outcomes of oxidant exposure.
Abstract: Organismal life encounters reactive oxidants from internal metabolism and environmental toxicant exposure. Reactive oxygen and nitrogen species cause oxidative stress and are traditionally viewed as being harmful. On the other hand, controlled production of oxidants in normal cells serves useful purposes to regulate signaling pathways. Reactive oxidants are counterbalanced by complex antioxidant defense systems regulated by a web of pathways to ensure that the response to oxidants is adequate for the body's needs. A recurrent theme in oxidant signaling and antioxidant defense is reactive cysteine thiol–based redox signaling. The nuclear factor erythroid 2–related factor 2 (Nrf2) is an emerging regulator of cellular resistance to oxidants. Nrf2 controls the basal and induced expression of an array of antioxidant response element–dependent genes to regulate the physiological and pathophysiological outcomes of oxidant exposure. This review discusses the impact of Nrf2 on oxidative stress and toxicity and how...

2,987 citations

Journal ArticleDOI
Leming Shi1, Laura H. Reid, Wendell D. Jones, Richard Shippy2, Janet A. Warrington3, Shawn C. Baker4, Patrick J. Collins5, Francoise de Longueville, Ernest S. Kawasaki6, Kathleen Y. Lee7, Yuling Luo, Yongming Andrew Sun7, James C. Willey8, Robert Setterquist7, Gavin M. Fischer9, Weida Tong1, Yvonne P. Dragan1, David J. Dix10, Felix W. Frueh1, Federico Goodsaid1, Damir Herman6, Roderick V. Jensen11, Charles D. Johnson, Edward K. Lobenhofer12, Raj K. Puri1, Uwe Scherf1, Jean Thierry-Mieg6, Charles Wang13, Michael A Wilson7, Paul K. Wolber5, Lu Zhang7, William Slikker1, Shashi Amur1, Wenjun Bao14, Catalin Barbacioru7, Anne Bergstrom Lucas5, Vincent Bertholet, Cecilie Boysen, Bud Bromley, Donna Brown, Alan Brunner2, Roger D. Canales7, Xiaoxi Megan Cao, Thomas A. Cebula1, James J. Chen1, Jing Cheng, Tzu Ming Chu14, Eugene Chudin4, John F. Corson5, J. Christopher Corton10, Lisa J. Croner15, Christopher Davies3, Timothy Davison, Glenda C. Delenstarr5, Xutao Deng13, David Dorris7, Aron Charles Eklund11, Xiaohui Fan1, Hong Fang, Stephanie Fulmer-Smentek5, James C. Fuscoe1, Kathryn Gallagher10, Weigong Ge1, Lei Guo1, Xu Guo3, Janet Hager16, Paul K. Haje, Jing Han1, Tao Han1, Heather Harbottle1, Stephen C. Harris1, Eli Hatchwell17, Craig A. Hauser18, Susan D. Hester10, Huixiao Hong, Patrick Hurban12, Scott A. Jackson1, Hanlee P. Ji19, Charles R. Knight, Winston Patrick Kuo20, J. Eugene LeClerc1, Shawn Levy21, Quan Zhen Li, Chunmei Liu3, Ying Liu22, Michael Lombardi11, Yunqing Ma, Scott R. Magnuson, Botoul Maqsodi, Timothy K. McDaniel3, Nan Mei1, Ola Myklebost23, Baitang Ning1, Natalia Novoradovskaya9, Michael S. Orr1, Terry Osborn, Adam Papallo11, Tucker A. Patterson1, Roger Perkins, Elizabeth Herness Peters, Ron L. Peterson24, Kenneth L. Philips12, P. Scott Pine1, Lajos Pusztai25, Feng Qian, Hongzu Ren10, Mitch Rosen10, Barry A. Rosenzweig1, Raymond R. Samaha7, Mark Schena, Gary P. Schroth, Svetlana Shchegrova5, Dave D. Smith26, Frank Staedtler24, Zhenqiang Su1, Hongmei Sun, Zoltan Szallasi20, Zivana Tezak1, Danielle Thierry-Mieg6, Karol L. Thompson1, Irina Tikhonova16, Yaron Turpaz3, Beena Vallanat10, Christophe Van, Stephen J. Walker27, Sue Jane Wang1, Yonghong Wang6, Russell D. Wolfinger14, Alexander Wong5, Jie Wu, Chunlin Xiao7, Qian Xie, Jun Xu13, Wen Yang, Liang Zhang, Sheng Zhong28, Yaping Zong 
TL;DR: This study describes the experimental design and probe mapping efforts behind the MicroArray Quality Control project and shows intraplatform consistency across test sites as well as a high level of interplatform concordance in terms of genes identified as differentially expressed.
Abstract: Over the last decade, the introduction of microarray technology has had a profound impact on gene expression research. The publication of studies with dissimilar or altogether contradictory results, obtained using different microarray platforms to analyze identical RNA samples, has raised concerns about the reliability of this technology. The MicroArray Quality Control (MAQC) project was initiated to address these concerns, as well as other performance and data analysis issues. Expression data on four titration pools from two distinct reference RNA samples were generated at multiple test sites using a variety of microarray-based and alternative technology platforms. Here we describe the experimental design and probe mapping efforts behind the MAQC project. We show intraplatform consistency across test sites as well as a high level of interplatform concordance in terms of genes identified as differentially expressed. This study provides a resource that represents an important first step toward establishing a framework for the use of microarrays in clinical and regulatory settings.

1,987 citations